-
Information-Publications
-
The negative effect of G1958A polymorphism on MTHFD1 protein stability and HCC growthDetails -
Oxoaporphine Pr (III) complex inhibits hepatocellular carcinoma progression and metastasis by disrupting tumor cell–macrophage crosstalkDetails -
Transcription factor EB (TFEB) participates in antiviral immune responses independent of mTORC1 in macrophage of large yellow croaker (Larimichthys crocea)Details -
Napabucasin attenuates resistance of breast cancer cells to tamoxifen by reducing stem cell-like propertiesDetails -
Six first-line tyrosine kinase inhibitors reveal novel inhibition potential for the EGFR S768I mutationDetails -
Molecular identification of peptidoglycan recognition protein 5 and its functional characterization in innate immunity of large yellow croaker, Larimichthys croceaDetails
-
"Heyuan Liji" is a joint venture between Heyuan Biotechnology (stock code: 688238) and Liji Biotechnology, specializing in the "Liji Biotechnology" and "Life-ilab" reagent brands
Back
